Mesh.i
Exploration
Accueil
Racine
Exploration
Accueil
Racine

Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « Mesh.i » - entrée « Antibodies »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Antibiotic Prophylaxis < Antibodies < Antibodies, Anti-Idiotypic  Facettes :

List of bibliographic references indexed by Antibodies

Number of relevant bibliographic references: 14.
Ident.Authors (with country if any)Title
001024 (2019) Tomohiro Koga [Japon] ; Remi Sumiyoshi [Japon] ; Atsushi Kawakami [Japon] ; Kazuyuki Yoshizaki [Japon]A benefit and the prospects of IL-6 inhibitors in idiopathic multicentric Castleman's disease.
001559 (2017) Melissa Y. Yeung [États-Unis] ; Steven Gabardi [États-Unis] ; Mohamed H. Sayegh [États-Unis]Use of polyclonal/monoclonal antibody therapies in transplantation.
001757 (2017) Gerd R. Burmester [Allemagne] ; Ernest Choy [Royaume-Uni] ; Alan Kivitz [États-Unis] ; Atsushi Ogata [Japon] ; Min Bao [États-Unis] ; Akira Nomura [Japon] ; Stuart Lacey [Royaume-Uni] ; Jinglan Pei [États-Unis] ; William Reiss [États-Unis] ; Attila Pethoe-Schramm [Suisse] ; Navita L. Mallalieu [États-Unis] ; Thomas Wallace [États-Unis] ; Margaret Michalska [États-Unis] ; Herbert Birnboeck [Suisse] ; Kay Stubenrauch [Allemagne] ; Mark C. Genovese [États-Unis]Low immunogenicity of tocilizumab in patients with rheumatoid arthritis.
001896 (2017) Dagur Ingi Jonsson [Suède] ; Ritva Pirskanen [Suède] ; Fredrik Piehl [Suède]Beneficial effect of tocilizumab in myasthenia gravis refractory to rituximab.
001A30 (2016) Shiho Fujiwara [Japon] ; Hiromi Mochinaga [Japon] ; Hirotomo Nakata [Japon] ; Koichi Ohshima [Japon] ; Masanori Matsumoto [Japon] ; Mitsuhiro Uchiba [Japon] ; Yoshiki Mikami [Japon] ; Hiroyuki Hata [Japon] ; Yutaka Okuno [Japon] ; Hiroaki Mitsuya [Japon] ; Kisato Nosaka [Japon]Successful treatment of TAFRO syndrome, a variant type of multicentric Castleman disease with thrombotic microangiopathy, with anti-IL-6 receptor antibody and steroids.
002051 (2015) Adrian Bot [États-Unis]Editorial: in this issue.
002327 (2014) Luca Semerano [France] ; Allan Thiolat ; Emeline Minichiello ; Gaëlle Clavel ; Natacha Bessis ; Marie-Christophe BoissierTargeting IL-6 for the treatment of rheumatoid arthritis: Phase II investigational drugs.
002690 (2013) Atsuko Wakabayashi [Japon] ; Kenjiro Sawada ; Masahiro Nakayama ; Aska Toda ; Akihito Kimoto ; Seiji Mabuchi ; Yasuto Kinose ; Koji Nakamura ; Kazuhiro Takahashi ; Hirohisa Kurachi ; Tadashi KimuraTargeting interleukin-6 receptor inhibits preterm delivery induced by inflammation.
003503 (2012) Jatinder P. Ahluwalia [États-Unis]Immunotherapy in inflammatory bowel disease.
003C29 (2010) Kay Stubenrauch [Allemagne] ; Uwe Wessels ; Herbert Birnboeck ; Francisco Ramirez ; Angelika Jahreis ; Julia SchleypenSubset analysis of patients experiencing clinical events of a potentially immunogenic nature in the pivotal clinical trials of tocilizumab for rheumatoid arthritis: Evaluation of an antidrug antibody ELISA using clinical adverse event-driven immunogenicity testing.
004063 (2008) Yasushi Uchiyama [Japon] ; Keigo Yorozu ; Misato Hashizume ; Yoichiro Moriya ; Masahiko MiharaTocilizumab, a humanized anti-interleukin-6 receptor antibody, ameliorates joint swelling in established monkey collagen-induced arthritis.
004201 (2007) M. Schneider [Allemagne]Exploring new territory: considering the future
004250 (2005) Masahiko Mihara [Japon] ; Norihiro Nishimoto ; Yoshiyuki OhsugiThe therapy of autoimmune diseases by anti-interleukin-6 receptor antibody.
004347 (????) Mikhail M. Kostik [Oman] ; Eugenia A. Isupova [Russie] ; Irina A. Chikova [Russie] ; Margarita F. Dubko [Russie] ; Vera V. Masalova [Russie] ; Ludmila S. Snegireva [Russie] ; Olga V. Kalashnikova [Russie] ; Vyacheslav G. Chasnyk [Russie]Reasons for inactive disease and flare in systemic onset juvenile idiopathic arthritis patients during tocilizumab treatment.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Antibodies" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Antibodies" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Antibodies
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021